BioSpace News Archive

Management to Host Conference Call on Monday, September 20, 2021 at 4:00 p.m. ET

Results of a new multinational survey of healthcare providers revealed that the majority of participants expect immunotherapy to have a positive impact on the treatment landscape for patients with earlier-stage cancers in the adjuvant (after surgery), neo-adjuvant (before surgery) and peri-operative (both before and after surgery) settings, if approved by regulatory bodies.

NeoImmuneTech, Inc. today announced that new data from a Phase 1/2 study evaluating the company’s lead asset NT-I7 (efineptakin alfa) will be presented during oral abstract sessions at the Society for Neuro-Oncology (SNO) annual meeting, to be held in Boston, Massachusetts on November 18-21, 2021.

Spectrum Pharmaceuticals today announced a late-breaking presentation of early poziotinib efficacy and safety data in first-line patients with non-small cell lung cancer (NSCLC) with HER2 exon 20 mutations from cohort 4 of the ZENITH20 clinical trial at the upcoming European Society for Medical Oncology Congress (ESMO) 2021 that will take place virtually September 16-20, 2021.

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, announced the 2021 award recipients for two new Health Equity and Inclusiveness award programs.

SIGA Technologies, Inc. announced the exercise of a procurement option under its 75A50118C00019 contract with Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services for the delivery of oral TPOXX® treatment courses valued at approximately $112.5 million to the U.S. government.

Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, today announced the publication of positive results from the RHINTRAC clinical trial in OTO Open.

Dovetail Genomics, the industry leader in advanced proximity ligation genomic solutions, today announced the expansion of its epigenetics services in the areas of both Bioinformatics and Target Enrichment, furthering the company’s commitment to offering one-stop solutions for sample-to-data processing, with data ready for downstream analysis and interpretation.

AccuraDX has launched the KAS-Direct™ ssDNA Labeling and Enrichment Kit to provide researchers with a simple and robust way to directly label and read out transcription activity genome-wide to identify cell states in different biological processes.

Apollo Endosurgery, Inc. today announced that its management team will participate in Lake Street’s 5th Annual Best Ideas Growth Conference. September 14-15, 2021